Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer
Barbara Schmalfeldt, Dieter Prechtel, Kathrin Härting, Kerstin Späthe, Stefan Rutke, Elisabeth Konik, Manfred Schmitt, Ursula Berger, Walther Kuhn, Ernst Lengyel, Ernst Lengyel
Research output: Contribution to journal › Article › peer-review
336Scopus
citations
Fingerprint
Dive into the research topics of 'Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer'. Together they form a unique fingerprint.